Clinical analysis of left ventricular assist device via minimally invasive thoracotomy
10.3760/cma.j.cn112434-20231212-00150
- VernacularTitle:微创肋间切口在心室辅助装置植入中的应用效果
- Author:
Fengwei GUO
1
;
Junjun HAO
;
Jing LI
;
Yan SONG
;
Yongxin LI
;
Yang YAN
Author Information
1. 西安交通大学第一附属医院心血管外科，西安 710061
- Keywords:
Minimally invasive;
Left ventricular assist device;
Clinical effects
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(5):257-261
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the effectiveness of left ventricular assist device (LVAD)implantation via minimally invasive thoracotomy.Methods:From April 2022 to October 2023, we retrospectively collected and analyzed the perioperative data of 16 patients underwent LVAD via minimally invasive thoracotomy in our institute. 16 patients included 10 males and 6 females, the mean age was(58.6±7.6)(49-76)years old, BSA was (1.75±0.90)(1.35-2.01)m 2, 6 cases of dilated cardiomyopathy (DCM), 8 cases of ischemic cardiomyopathy (ICM) and 2 cases of end-stage valvular heart disease. LVAD type included 8 cases of CH-VAD, 7 cases of HeartCon and 1 case of Corheart-6. All the 16 patients underwent LVAD implantation were performed in condition of CPB, 13 patients on-beating heart, 3 patients with heart arrest. The outflow graft of 15 patients were place at ascending aorta, 1 patient was descending aorta. Results:The average surgical time was about 5.09 h, CPB time was(137±32)min, and the mechanical ventilation time was (20.8±13.6)h, stay in the ICU was(10.0±6.3)days, and the length of stay was(45.4±17.0)days. No case transition to sternotomy, no case in right ventricular failure, and no death case during 30 days.Conclusion:Minimally invasive thoracotomy approach is a safe and reliable method for left ventricular assist devices implantation, and can be used as a choice for LVAD implantation.
